MEK inhibitors against MET-amplified non-small cell lung cancer

MEK inhibitors against MET-amplified non-small cell lung cancer

Several receptor tyrosine kinases (RTKs) including EGFR, ALK, and MET have been identified as therapeutic targets in non-small cell lung cancer (NSCLC). Among the downstream pathways of RTKs, the MAPK pathway is particularly important for cancer cell proliferation, differentiation, and survival. In...

Full description

Bibliographic Details
Main Authors:	Chiba, Masato, Togashi, Yosuke, Tomida, Shuta, Mizuuchi, Hiroshi, Nakamura, Yu, Banno, Eri, Hayashi, Hidetoshi, Terashima, Masato, De Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Mitsudomi, Tetsuya, Nishio, Kazuto
Format:	Online
Language:	English
Published:	D.A. Spandidos 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118002/

Similar Items

KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival
by: Terashima, Masato, et al.
Published: (2014)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
by: Banno, Eri, et al.
Published: (2016)

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A
by: Masato Chiba, et al.
Published: (2017-04-01)

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer
by: Togashi, Yosuke, et al.
Published: (2014)

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition
by: KOGITA, AKIHIRO, et al.
Published: (2014)

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines
by: Terashima, Masato, et al.
Published: (2014)

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
by: Sakai, Kazuko, et al.
Published: (2015)

Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer
by: Sakai, Kazuko, et al.
Published: (2015)

Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib
by: Mizuuchi, Hiroshi, et al.
Published: (2015)

Melanoma Transition Is Frequently Accompanied by a Loss of Cytoglobin Expression in Melanocytes: A Novel Expression Site of Cytoglobin
by: Fujita, Yoshihiko, et al.
Published: (2014)

FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib
by: Hibi, Masaaki, et al.
Published: (2016)

Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production
by: Togashi, Yosuke, et al.
Published: (2013)

Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer
by: Suda, Kenichi, et al.
Published: (2015)

Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor in lung cancer
by: Mizuuchi, Hiroshi, et al.
Published: (2016)

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression
by: Sato, Katsuaki, et al.
Published: (2016)

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
by: Togashi, Yosuke, et al.
Published: (2014)

Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions
by: Sakai, Kazuko, et al.
Published: (2014)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
by: KATO, HIROAKI, et al.
Published: (2013)

Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoter
by: SAKAI, KAZUKO, et al.
Published: (2015)

Targeting MET Amplification as a New Oncogenic Driver
by: Kawakami, Hisato, et al.
Published: (2014)

Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells
by: Tamura, Daisuke, et al.
Published: (2013)

MET amplification as a potential therapeutic target in gastric cancer
by: Kawakami, Hisato, et al.
Published: (2012)

Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts
by: LIU, KAI, et al.
Published: (2015)

An Intriguing Correlation Based on the Superimposition of Residue Pairs with Inhibitors that Target Protein-Protein Interfaces
by: Nakadai, Masakazu, et al.
Published: (2016)

Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2
by: Yoshida, Takayuki, et al.
Published: (2012)

Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts
by: Ji, Fujian, et al.
Published: (2015)

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma
by: Hayashi, Hidetoshi, et al.
Published: (2014)

Clinical Outcomes of Varicocele Repair in Infertile Men: A Review
by: Chiba, Koji, et al.
Published: (2016)

Overexpression of heparan sulfate 6-O-sulfotransferase-2 in colorectal cancer
by: HATABE, SHIGERU, et al.
Published: (2013)

Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding
by: Shiotani, Akiko, et al.
Published: (2013)

Met in Urological Cancers
by: Miyata, Yasuyoshi, et al.
Published: (2014)

Akrab martabatkan Mek Mulung
by: Utusan Malaysia, Saharudin Musthafa
Published: (2017)

MEK genomics in development and disease
by: Bromberg-White, Jennifer L., et al.
Published: (2012)

New features in MEK retinopathy
by: Pallavi Tyagi, et al.
Published: (2018-09-01)

Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
by: Yamashita, Yoriko, et al.
Published: (2013)

Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
by: Palma, Norma A., et al.
Published: (2014)

MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection
by: Lee, Dakeun, et al.
Published: (2015)

Point-of-care ultrasound detection of tracheal wall thickening caused by smoke inhalation
by: Kameda, Toru, et al.
Published: (2014)

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
by: Tanizaki, J, et al.
Published: (2012)

Draft Genome Sequence of Probiotic Lactobacillus acidophilus Strain L-55 Isolated from a Healthy Human Gut
by: Fujii, Yusuke, et al.
Published: (2016)